Literature DB >> 1847703

Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography.

B Sadzot1, J C Price, H S Mayberg, K H Douglass, R F Dannals, J R Lever, H T Ravert, A A Wilson, H N Wagner, M A Feldman.   

Abstract

[11C]Diprenorphine, a weak partial opiate agonist, and positron emission tomography were used to obtain noninvasive regional estimates of opiate receptor concentration (Bmax) and affinity (Kd) in human brain. Different compartmental models and fitting strategies were compared statistically to establish the most reliable method of parameter estimation. Paired studies were performed in six normal subjects using high (769-5,920 Ci/mmol) and low (27-80 Ci/mmol) specific activity (SA) [11C]diprenorphine. Two subjects were studied a third time using high SA [11C]diprenorphine after a pretreatment with 1-1.5 mg/kg of the opiate antagonist naloxone. After the plasma radioactivity was corrected for metabolites, the brain data were analyzed using a three-compartment model and nonlinear least-squares curve fitting. Linear differential equations were used to describe the high SA (low receptor occupancy) kinetics. The k3/k4 ratio varied from 1.0 +/- 0.2 (occipital cortex) to 8.6 +/- 1.6 (thalamus). Nonlinear differential equations were used to describe the low SA (high receptor occupancy) kinetics and the curve fits provided the konf2 product. The measured free fraction of [11C]diprenorphine in plasma (f1) was 0.30 +/- 0.03, the average K1/k2 ratio from the two naloxone studies was 1.1 +/- 0.2, and the calculated free fraction of [11C]diprenorphine in the brain (f2) was 0.3. Using the paired SA studies, the estimated kinetic parameters, and f2, separate estimates of Bmax and Kd were obtained. Bmax varied from 2.3 +/- 0.5 (occipital cortex) to 20.6 +/- 7.3 (cingulate cortex) nM. The average Kd (eight brain regions) was 0.85 +/- 0.17 nM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847703     DOI: 10.1038/jcbfm.1991.52

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  Effects of morphine and alcohol on functional brain connectivity during "resting state": a placebo-controlled crossover study in healthy young men.

Authors:  Najmeh Khalili-Mahani; Remco M W Zoethout; Christian F Beckmann; Evelinda Baerends; Marieke L de Kam; Roelof P Soeter; Albert Dahan; Mark A van Buchem; Joop M A van Gerven; Serge A R B Rombouts
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

Review 2.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  Molecular imaging of levodopa-induced dyskinesias.

Authors:  Flavia Niccolini; Lorenzo Rocchi; Marios Politis
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

4.  Generalized paired-agent kinetic model for in vivo quantification of cancer cell-surface receptors under receptor saturation conditions.

Authors:  N Sadeghipour; S C Davis; K M Tichauer
Journal:  Phys Med Biol       Date:  2016-12-20       Impact factor: 3.609

5.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Authors:  Darin D Dougherty; Jian Kong; Megan Webb; Ali A Bonab; Alan J Fischman; Randy L Gollub
Journal:  Behav Brain Res       Date:  2008-05-02       Impact factor: 3.332

6.  Investigation of the opioid system in absence seizures with positron emission tomography.

Authors:  P A Bartenstein; J S Duncan; M C Prevett; V J Cunningham; D R Fish; A K Jones; S K Luthra; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

7.  Evidence for modulation of opioidergic activity in central vestibular processing: A [(18)F] diprenorphine PET study.

Authors:  Bernhard Baier; Sandra Bense; Frank Birklein; Hans-Georg Buchholz; Anja Mischke; Matthias Schreckenberger; Marianne Dieterich
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

8.  PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function.

Authors:  K J Black; M H Gado; J S Perlmutter
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

9.  In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Authors:  Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Ningning Guo; Yasuhiko Sudo; Raj Narendran; Peter Talbot; Marc Laruelle
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

Review 10.  Role of the Anterior Cingulate Cortex in Translational Pain Research.

Authors:  Xiao Xiao; Ming Ding; Yu-Qiu Zhang
Journal:  Neurosci Bull       Date:  2021-02-10       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.